The emerging era of personalized medicine relies on medical decisions, practices, and products being tailored to the individual patient. Point-of-care systems, at the heart of this model, play two important roles. First, they are required for identifying subjects for optimal therapies based on their genetic make-up and epigenetic profile. Second, they will be used for assessing the progression of such therapies. Central to this vision is designing systems that, with minimal user-intervention, can transduce complex signals from biosystems in complement with clinical information to inform medical decision within point-of-care settings. To reach our ultimate goal of developing point-of-care systems and realizing personalized medicine, we are taking a multistep systems-level approach towards Table of Contents Chapter 1: Analyzing biomarker profiles in blood serum to enable early detection of cancer 6 Nanoslit design for ion conductivity gradient enhanced dielectrophoresis for ultrafast biomarker enrichment in physiological media 9 Quantifying spatio-temporal dynamics of biomarker pre-concentration and depletion in microfluidic systems using their statistical distribution 30 Frequency-selective enrichment of biomolecules in physiological media based on electrical double-layer induced polarization 40 Chapter 2: Probing mitochondrial morphological patterns as a new cancer biomarker 56 Predictive analytics platform for studying cancer and neurodegenerative diseases by probing mitochondrial morphological patterns as a new biomarker 59 Label-free quantification of alterations in intracellular mitochondrial dynamics by monitoring cytoplasmic conductivity 74 Publications & Patents